The cancer center saw its total operating revenue decline 2.9 percent year over year to $3.8 billion. Memorial Sloan Kettering said the revenue decline was attributed to declining patient volumes and a slowdown of clinical trials and research due to COVID-19.
Memorial Sloan Kettering also saw its expenses rise 10.8 percent year over year to $4.3 billion. The cancer center saw its compensation and benefits costs increase 12 percent and supply costs increase 3.4 percent.
Through the nine-month period ended Sept. 30, Memorial Sloan Kettering saw its net assets without donor restrictions increase $85.1 million. This compares to an increase of $498.3 million through the same period in 2019.
More articles on healthcare finance:
‘COVID’ fee showing up on medical bills across the country
Hospitals lose billions in hit to medical tourism
‘2020 was truly a baptism by fire’: Tampa General CFO reflects on his first year
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
